Company intelligence / Profile preview

Shin Nippon Biomedical Laboratories

Tokyo, Tokyo, Japansnbl-nds.com ↗
Ownership
Private
Employees
~1341
Development stage
NDA
01

Overview

SNBL operates as Japan’s first contract research organization with over six decades of experience. It provides comprehensive non-clinical and clinical trial support to pharmaceutical and biotech companies globally. Its proprietary SMART nasal drug delivery platform underpins at least one FDA-approved product for acute migraine treatment. The company also engages in translational research, device development, regenerative medicine safety studies, and maintains strong academic collaborations.

Therapeutic areas
OtherOncologyNeurology
Modalities
Small molecule (as part of drug development services)Biologic (as part of drug development services)Device (notably nasal drug delivery devices)Nasal powder formulationRecombinant protein (supported in preclinical/clinical studies)Cell therapy and regenerative medicine support
Industry
Contract Research Organization
02

Drug pipeline

1 asset

levodopa (intranasal, TR-012001)

2
03

Partnerships

PPD/Thermo Fisher Scientific joint venture “PPD-SNBL” for clinical trial management in JapanLicensing partnerships with pharmaceutical companies using the SMART technology

Beyond the preview

Go deeper on Shin Nippon Biomedical Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shin Nippon Biomedical Laboratories.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call